Stay updated on ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2; this appears to be an internal site update and does not affect the study details.
    Difference
    0.0%
    Check dated 2026-04-16T10:39:36.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T15:53:37.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and the previous revision label v3.4.2 was removed. This update is a minor maintenance change and does not affect study details.
    Difference
    0.0%
    Check dated 2026-03-11T14:44:00.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The previous government funding-status notice and Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:16:11.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added a system-wide notice about a lapse in government funding affecting site updates and directing users to cc.nih.gov and opm.gov for status. Updated the site to version v3.4.1 (from v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T00:40:25.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The changes are limited to UI and metadata updates (glossary display, new labels such as 'Last Update Submitted that Met QC Criteria', 'Last Update Posted', 'No FEAR Act Data', and revision 'v3.4.0'), with no changes to core study content, eligibility criteria, outcomes, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T22:53:48.000Z thumbnail image

Stay in the know with updates to ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.